Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Amgen Selects West's SmartDose Delivery Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

Amgen Selects West’s SmartDose Delivery Platform

On-body infusor with prefilled cartridge to deliver monthly single dose of Repatha

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Amgen has received FDA approval for a single, monthly 420 mg dose delivery option for Repatha (evolocumab), using West Pharmaceutical Services’ SmartDose technology.
 
“West is very pleased that Amgen has selected the SmartDose technology platform for the new monthly single dose administration option of Repatha,” said Eric M. Green, president and chief executive officer, West. “The combination of Amgen’s innovative treatment with West’s patient-focused technology platform is an example of how West closely collaborates with our pharmaceutical and biotechnology partners to deliver advanced, integrated solutions for drug delivery and containment.”
 
The SmartDose technology allows patients to self-administer medication via a platform that adheres to the patient’s body, usually on the abdomen, for hands free administration. The SmartDose technology platform is an integrated solution of delivery and containment featuring a silicone-free Daikyo Crystal Zenith cartridge and a Flurotec coated piston containment system.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics